nodes	percent_of_prediction	percent_of_DWPC	metapath
Salsalate—PTGS2—Risedronate—osteoporosis	0.764	1	CbGbCtD
Salsalate—Creatinine low—Zoledronate—osteoporosis	0.0184	0.0789	CcSEcCtD
Salsalate—Blood creatinine decreased—Zoledronate—osteoporosis	0.0168	0.0722	CcSEcCtD
Salsalate—Deafness—Ibandronate—osteoporosis	0.004	0.0171	CcSEcCtD
Salsalate—Bronchospasm—Ibandronate—osteoporosis	0.00304	0.013	CcSEcCtD
Salsalate—Hypotension—Calcium Acetate—osteoporosis	0.00302	0.0129	CcSEcCtD
Salsalate—Hearing impaired—Estradiol—osteoporosis	0.00285	0.0122	CcSEcCtD
Salsalate—Haemoglobin—Alendronate—osteoporosis	0.00255	0.011	CcSEcCtD
Salsalate—Haemorrhage—Alendronate—osteoporosis	0.00254	0.0109	CcSEcCtD
Salsalate—Haemoglobin—Ibandronate—osteoporosis	0.00249	0.0107	CcSEcCtD
Salsalate—Haemorrhage—Ibandronate—osteoporosis	0.00247	0.0106	CcSEcCtD
Salsalate—Haemoglobin—Calcitriol—osteoporosis	0.00243	0.0104	CcSEcCtD
Salsalate—Haemorrhage—Calcitriol—osteoporosis	0.00242	0.0104	CcSEcCtD
Salsalate—Bronchospasm—Pamidronate—osteoporosis	0.00238	0.0102	CcSEcCtD
Salsalate—Angioedema—Etidronic acid—osteoporosis	0.00237	0.0102	CcSEcCtD
Salsalate—Diarrhoea—Calcium Acetate—osteoporosis	0.00221	0.00947	CcSEcCtD
Salsalate—Deafness—Estradiol—osteoporosis	0.00221	0.00946	CcSEcCtD
Salsalate—Bronchospasm—Zoledronate—osteoporosis	0.00218	0.00933	CcSEcCtD
Salsalate—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.0021	0.00902	CcSEcCtD
Salsalate—Bronchospasm—Conjugated Estrogens—osteoporosis	0.0021	0.00899	CcSEcCtD
Salsalate—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00209	0.00897	CcSEcCtD
Salsalate—Angioedema—Estropipate—osteoporosis	0.00205	0.0088	CcSEcCtD
Salsalate—Haemoglobin—Risedronate—osteoporosis	0.00205	0.00879	CcSEcCtD
Salsalate—Haemorrhage—Risedronate—osteoporosis	0.00204	0.00875	CcSEcCtD
Salsalate—Angioedema—Alendronate—osteoporosis	0.00202	0.00867	CcSEcCtD
Salsalate—Vertigo—Estropipate—osteoporosis	0.00202	0.00866	CcSEcCtD
Salsalate—Vertigo—Alendronate—osteoporosis	0.00199	0.00853	CcSEcCtD
Salsalate—Angioedema—Ibandronate—osteoporosis	0.00197	0.00844	CcSEcCtD
Salsalate—Vertigo—Raloxifene—osteoporosis	0.00195	0.00838	CcSEcCtD
Salsalate—Haemoglobin—Pamidronate—osteoporosis	0.00195	0.00836	CcSEcCtD
Salsalate—Haemorrhage—Pamidronate—osteoporosis	0.00194	0.00831	CcSEcCtD
Salsalate—Vertigo—Ibandronate—osteoporosis	0.00194	0.0083	CcSEcCtD
Salsalate—Nausea—Calcium Acetate—osteoporosis	0.00192	0.00822	CcSEcCtD
Salsalate—Tinnitus—Risedronate—osteoporosis	0.0019	0.00816	CcSEcCtD
Salsalate—Anaphylactic shock—Estropipate—osteoporosis	0.00183	0.00786	CcSEcCtD
Salsalate—Anaphylactic shock—Ibandronate—osteoporosis	0.00176	0.00754	CcSEcCtD
Salsalate—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00173	0.00743	CcSEcCtD
Salsalate—Anaphylactic shock—Calcitriol—osteoporosis	0.00172	0.00738	CcSEcCtD
Salsalate—Nausea—Ergocalciferol—osteoporosis	0.00169	0.00726	CcSEcCtD
Salsalate—Urticaria—Etidronic acid—osteoporosis	0.00168	0.00722	CcSEcCtD
Salsalate—Bronchospasm—Estradiol—osteoporosis	0.00168	0.00719	CcSEcCtD
Salsalate—Abdominal pain—Etidronic acid—osteoporosis	0.00168	0.00719	CcSEcCtD
Salsalate—Angioedema—Ethinyl Estradiol—osteoporosis	0.00166	0.00714	CcSEcCtD
Salsalate—Angioedema—Risedronate—osteoporosis	0.00162	0.00696	CcSEcCtD
Salsalate—Vertigo—Risedronate—osteoporosis	0.00159	0.00684	CcSEcCtD
Salsalate—Angioedema—Pamidronate—osteoporosis	0.00154	0.00661	CcSEcCtD
Salsalate—Gastrointestinal pain—Estropipate—osteoporosis	0.0015	0.00643	CcSEcCtD
Salsalate—Gastrointestinal pain—Alendronate—osteoporosis	0.00148	0.00633	CcSEcCtD
Salsalate—Urticaria—Estropipate—osteoporosis	0.00146	0.00625	CcSEcCtD
Salsalate—Gastrointestinal pain—Raloxifene—osteoporosis	0.00145	0.00623	CcSEcCtD
Salsalate—Diarrhoea—Etidronic acid—osteoporosis	0.00145	0.00622	CcSEcCtD
Salsalate—Abdominal pain—Estropipate—osteoporosis	0.00145	0.00622	CcSEcCtD
Salsalate—Gastrointestinal pain—Ibandronate—osteoporosis	0.00144	0.00617	CcSEcCtD
Salsalate—Urticaria—Alendronate—osteoporosis	0.00143	0.00615	CcSEcCtD
Salsalate—Abdominal pain—Alendronate—osteoporosis	0.00143	0.00612	CcSEcCtD
Salsalate—Angioedema—Zoledronate—osteoporosis	0.00141	0.00604	CcSEcCtD
Salsalate—Gastrointestinal pain—Calcitriol—osteoporosis	0.00141	0.00604	CcSEcCtD
Salsalate—Abdominal pain—Raloxifene—osteoporosis	0.0014	0.00602	CcSEcCtD
Salsalate—Urticaria—Ibandronate—osteoporosis	0.0014	0.00599	CcSEcCtD
Salsalate—Abdominal pain—Ibandronate—osteoporosis	0.00139	0.00596	CcSEcCtD
Salsalate—Vertigo—Zoledronate—osteoporosis	0.00138	0.00594	CcSEcCtD
Salsalate—Anaphylactic shock—Pamidronate—osteoporosis	0.00138	0.00591	CcSEcCtD
Salsalate—Haemoglobin—Estradiol—osteoporosis	0.00137	0.00588	CcSEcCtD
Salsalate—Urticaria—Calcitriol—osteoporosis	0.00137	0.00586	CcSEcCtD
Salsalate—Haemorrhage—Estradiol—osteoporosis	0.00136	0.00585	CcSEcCtD
Salsalate—Hepatitis—Estradiol—osteoporosis	0.00136	0.00585	CcSEcCtD
Salsalate—Abdominal pain—Calcitriol—osteoporosis	0.00136	0.00584	CcSEcCtD
Salsalate—Angioedema—Conjugated Estrogens—osteoporosis	0.00136	0.00582	CcSEcCtD
Salsalate—Rash—Etidronic acid—osteoporosis	0.00134	0.00573	CcSEcCtD
Salsalate—Dermatitis—Etidronic acid—osteoporosis	0.00133	0.00573	CcSEcCtD
Salsalate—Vertigo—Conjugated Estrogens—osteoporosis	0.00133	0.00572	CcSEcCtD
Salsalate—Hypotension—Pamidronate—osteoporosis	0.00129	0.00552	CcSEcCtD
Salsalate—Tinnitus—Estradiol—osteoporosis	0.00127	0.00546	CcSEcCtD
Salsalate—Nausea—Etidronic acid—osteoporosis	0.00126	0.0054	CcSEcCtD
Salsalate—Anaphylactic shock—Zoledronate—osteoporosis	0.00126	0.0054	CcSEcCtD
Salsalate—Diarrhoea—Estropipate—osteoporosis	0.00125	0.00538	CcSEcCtD
Salsalate—Diarrhoea—Alendronate—osteoporosis	0.00124	0.0053	CcSEcCtD
Salsalate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00122	0.00521	CcSEcCtD
Salsalate—Diarrhoea—Raloxifene—osteoporosis	0.00122	0.00521	CcSEcCtD
Salsalate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00121	0.0052	CcSEcCtD
Salsalate—Diarrhoea—Ibandronate—osteoporosis	0.0012	0.00516	CcSEcCtD
Salsalate—Gastrointestinal pain—Risedronate—osteoporosis	0.00118	0.00508	CcSEcCtD
Salsalate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00118	0.00506	CcSEcCtD
Salsalate—Diarrhoea—Calcitriol—osteoporosis	0.00118	0.00505	CcSEcCtD
Salsalate—Hypotension—Zoledronate—osteoporosis	0.00118	0.00504	CcSEcCtD
Salsalate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00117	0.00504	CcSEcCtD
Salsalate—Rash—Estropipate—osteoporosis	0.00116	0.00496	CcSEcCtD
Salsalate—Dermatitis—Estropipate—osteoporosis	0.00115	0.00495	CcSEcCtD
Salsalate—Urticaria—Risedronate—osteoporosis	0.00115	0.00494	CcSEcCtD
Salsalate—Abdominal pain—Risedronate—osteoporosis	0.00115	0.00491	CcSEcCtD
Salsalate—Rash—Alendronate—osteoporosis	0.00114	0.00488	CcSEcCtD
Salsalate—Dermatitis—Alendronate—osteoporosis	0.00114	0.00488	CcSEcCtD
Salsalate—Hypotension—Conjugated Estrogens—osteoporosis	0.00113	0.00485	CcSEcCtD
Salsalate—Gastrointestinal pain—Pamidronate—osteoporosis	0.00113	0.00483	CcSEcCtD
Salsalate—Rash—Raloxifene—osteoporosis	0.00112	0.0048	CcSEcCtD
Salsalate—Dermatitis—Raloxifene—osteoporosis	0.00112	0.0048	CcSEcCtD
Salsalate—Rash—Ibandronate—osteoporosis	0.00111	0.00475	CcSEcCtD
Salsalate—Dermatitis—Ibandronate—osteoporosis	0.00111	0.00475	CcSEcCtD
Salsalate—Nausea—Estropipate—osteoporosis	0.00109	0.00467	CcSEcCtD
Salsalate—Abdominal pain—Pamidronate—osteoporosis	0.00109	0.00467	CcSEcCtD
Salsalate—Angioedema—Estradiol—osteoporosis	0.00109	0.00466	CcSEcCtD
Salsalate—Rash—Calcitriol—osteoporosis	0.00109	0.00465	CcSEcCtD
Salsalate—Dermatitis—Calcitriol—osteoporosis	0.00108	0.00465	CcSEcCtD
Salsalate—Nausea—Alendronate—osteoporosis	0.00107	0.0046	CcSEcCtD
Salsalate—Vertigo—Estradiol—osteoporosis	0.00107	0.00458	CcSEcCtD
Salsalate—Nausea—Raloxifene—osteoporosis	0.00105	0.00452	CcSEcCtD
Salsalate—Nausea—Ibandronate—osteoporosis	0.00104	0.00448	CcSEcCtD
Salsalate—Gastrointestinal pain—Zoledronate—osteoporosis	0.00103	0.00441	CcSEcCtD
Salsalate—Nausea—Calcitriol—osteoporosis	0.00102	0.00438	CcSEcCtD
Salsalate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00102	0.00436	CcSEcCtD
Salsalate—Urticaria—Zoledronate—osteoporosis	0.000999	0.00429	CcSEcCtD
Salsalate—Abdominal pain—Zoledronate—osteoporosis	0.000995	0.00427	CcSEcCtD
Salsalate—Diarrhoea—Risedronate—osteoporosis	0.000991	0.00425	CcSEcCtD
Salsalate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000991	0.00425	CcSEcCtD
Salsalate—Anaphylactic shock—Estradiol—osteoporosis	0.00097	0.00416	CcSEcCtD
Salsalate—Urticaria—Conjugated Estrogens—osteoporosis	0.000962	0.00413	CcSEcCtD
Salsalate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000958	0.00411	CcSEcCtD
Salsalate—Diarrhoea—Pamidronate—osteoporosis	0.000942	0.00404	CcSEcCtD
Salsalate—Rash—Ethinyl Estradiol—osteoporosis	0.000937	0.00402	CcSEcCtD
Salsalate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000936	0.00401	CcSEcCtD
Salsalate—Rash—Risedronate—osteoporosis	0.000914	0.00392	CcSEcCtD
Salsalate—Dermatitis—Risedronate—osteoporosis	0.000913	0.00391	CcSEcCtD
Salsalate—Nausea—Ethinyl Estradiol—osteoporosis	0.000883	0.00379	CcSEcCtD
Salsalate—Rash—Pamidronate—osteoporosis	0.000868	0.00372	CcSEcCtD
Salsalate—Dermatitis—Pamidronate—osteoporosis	0.000868	0.00372	CcSEcCtD
Salsalate—Diarrhoea—Zoledronate—osteoporosis	0.000861	0.00369	CcSEcCtD
Salsalate—Nausea—Risedronate—osteoporosis	0.000861	0.00369	CcSEcCtD
Salsalate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000829	0.00355	CcSEcCtD
Salsalate—Nausea—Pamidronate—osteoporosis	0.000818	0.00351	CcSEcCtD
Salsalate—Rash—Zoledronate—osteoporosis	0.000793	0.0034	CcSEcCtD
Salsalate—Gastrointestinal pain—Estradiol—osteoporosis	0.000793	0.0034	CcSEcCtD
Salsalate—Dermatitis—Zoledronate—osteoporosis	0.000793	0.0034	CcSEcCtD
Salsalate—Urticaria—Estradiol—osteoporosis	0.00077	0.0033	CcSEcCtD
Salsalate—Abdominal pain—Estradiol—osteoporosis	0.000766	0.00329	CcSEcCtD
Salsalate—Rash—Conjugated Estrogens—osteoporosis	0.000764	0.00328	CcSEcCtD
Salsalate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000763	0.00327	CcSEcCtD
Salsalate—Nausea—Zoledronate—osteoporosis	0.000747	0.00321	CcSEcCtD
Salsalate—Nausea—Conjugated Estrogens—osteoporosis	0.00072	0.00309	CcSEcCtD
Salsalate—Diarrhoea—Estradiol—osteoporosis	0.000663	0.00285	CcSEcCtD
Salsalate—Rash—Estradiol—osteoporosis	0.000611	0.00262	CcSEcCtD
Salsalate—Dermatitis—Estradiol—osteoporosis	0.000611	0.00262	CcSEcCtD
Salsalate—Nausea—Estradiol—osteoporosis	0.000576	0.00247	CcSEcCtD
Salsalate—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.000236	0.0742	CbGpPWpGaD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000219	0.069	CbGpPWpGaD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.000174	0.0548	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000134	0.0421	CbGpPWpGaD
Salsalate—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.000124	0.039	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000106	0.0334	CbGpPWpGaD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.92e-05	0.0281	CbGpPWpGaD
Salsalate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	8.01e-05	0.0252	CbGpPWpGaD
Salsalate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	6.31e-05	0.0199	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	5.57e-05	0.0175	CbGpPWpGaD
Salsalate—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	5.44e-05	0.0171	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	5.06e-05	0.0159	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—CYP27A1—osteoporosis	4.74e-05	0.0149	CbGpPWpGaD
Salsalate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	4.72e-05	0.0149	CbGpPWpGaD
Salsalate—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	4.69e-05	0.0148	CbGpPWpGaD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.68e-05	0.0148	CbGpPWpGaD
Salsalate—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	4.32e-05	0.0136	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	3.79e-05	0.0119	CbGpPWpGaD
Salsalate—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	3.79e-05	0.0119	CbGpPWpGaD
Salsalate—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	3.72e-05	0.0117	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	3.63e-05	0.0114	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	3.46e-05	0.0109	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	3.2e-05	0.0101	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.17e-05	0.00997	CbGpPWpGaD
Salsalate—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	3.01e-05	0.00947	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3e-05	0.00946	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	2.88e-05	0.00908	CbGpPWpGaD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.82e-05	0.00887	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.81e-05	0.00885	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	2.75e-05	0.00866	CbGpPWpGaD
Salsalate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	2.56e-05	0.00806	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	2.54e-05	0.00799	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.51e-05	0.00792	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—CYP19A1—osteoporosis	2.49e-05	0.00784	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.38e-05	0.00751	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.33e-05	0.00735	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.28e-05	0.00717	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2e-05	0.0063	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.97e-05	0.00621	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	1.9e-05	0.00597	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—LEP—osteoporosis	1.87e-05	0.00588	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.85e-05	0.00584	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.84e-05	0.00578	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.82e-05	0.00573	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.81e-05	0.00569	CbGpPWpGaD
Salsalate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	1.72e-05	0.00541	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.55e-05	0.00487	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	1.51e-05	0.00474	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—POMC—osteoporosis	1.5e-05	0.00471	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.44e-05	0.00455	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PKM—osteoporosis	1.41e-05	0.00444	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—FDPS—osteoporosis	1.41e-05	0.00444	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	1.38e-05	0.00434	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PGLS—osteoporosis	1.34e-05	0.00421	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GPD2—osteoporosis	1.34e-05	0.00421	CbGpPWpGaD
Salsalate—PTGS2—Disease—PKM—osteoporosis	1.34e-05	0.00421	CbGpPWpGaD
Salsalate—PTGS2—Disease—SOST—osteoporosis	1.34e-05	0.00421	CbGpPWpGaD
Salsalate—PTGS2—Disease—PGLS—osteoporosis	1.27e-05	0.00399	CbGpPWpGaD
Salsalate—PTGS2—Disease—ANTXR2—osteoporosis	1.27e-05	0.00399	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.23e-05	0.00387	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PNP—osteoporosis	1.22e-05	0.00385	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ATIC—osteoporosis	1.22e-05	0.00385	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	1.22e-05	0.00383	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.21e-05	0.00382	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	1.19e-05	0.00375	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—PKM—osteoporosis	1.12e-05	0.00353	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—FDPS—osteoporosis	1.12e-05	0.00353	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	1.11e-05	0.0035	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	1.09e-05	0.00344	CbGpPWpGaD
Salsalate—PTGS2—Disease—GSN—osteoporosis	1.08e-05	0.00339	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—PGLS—osteoporosis	1.06e-05	0.00334	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GPD2—osteoporosis	1.06e-05	0.00334	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.05e-05	0.00331	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—OXCT1—osteoporosis	1.04e-05	0.00327	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CA2—osteoporosis	1.04e-05	0.00327	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—MGLL—osteoporosis	1.01e-05	0.00319	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—PNP—osteoporosis	9.71e-06	0.00306	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ATIC—osteoporosis	9.71e-06	0.00306	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.56e-06	0.00301	CbGpPWpGaD
Salsalate—PTGS2—Disease—LRP5—osteoporosis	9.38e-06	0.00295	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—MYC—osteoporosis	9.28e-06	0.00292	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	9.25e-06	0.00291	CbGpPWpGaD
Salsalate—PTGS2—Disease—LRP6—osteoporosis	8.97e-06	0.00282	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	8.82e-06	0.00278	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TNF—osteoporosis	8.64e-06	0.00272	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—IDH2—osteoporosis	8.62e-06	0.00271	CbGpPWpGaD
Salsalate—PTGS2—Disease—LTF—osteoporosis	8.62e-06	0.00271	CbGpPWpGaD
Salsalate—PTGS2—Disease—RPL24—osteoporosis	8.62e-06	0.00271	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—OXCT1—osteoporosis	8.26e-06	0.0026	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CA2—osteoporosis	8.26e-06	0.0026	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CYP27A1—osteoporosis	8.1e-06	0.00255	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—MGLL—osteoporosis	8.04e-06	0.00253	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ACP5—osteoporosis	7.88e-06	0.00248	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.78e-06	0.00245	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.59e-06	0.00239	CbGpPWpGaD
Salsalate—PTGS2—Disease—ACP5—osteoporosis	7.47e-06	0.00235	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—TPI1—osteoporosis	7.33e-06	0.00231	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—IL6—osteoporosis	6.97e-06	0.0022	CbGpPWpGaD
Salsalate—PTGS2—Disease—TPI1—osteoporosis	6.94e-06	0.00219	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—P4HB—osteoporosis	6.89e-06	0.00217	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—IDH2—osteoporosis	6.84e-06	0.00215	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GAPDH—osteoporosis	6.76e-06	0.00213	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—RAP1A—osteoporosis	6.59e-06	0.00207	CbGpPWpGaD
Salsalate—PTGS2—Disease—P4HB—osteoporosis	6.53e-06	0.00206	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CYP27A1—osteoporosis	6.43e-06	0.00203	CbGpPWpGaD
Salsalate—PTGS2—Disease—GAPDH—osteoporosis	6.41e-06	0.00202	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.31e-06	0.00199	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.3e-06	0.00198	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ACP5—osteoporosis	6.26e-06	0.00197	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.18e-06	0.00195	CbGpPWpGaD
Salsalate—PTGS2—Disease—NFATC1—osteoporosis	6.09e-06	0.00192	CbGpPWpGaD
Salsalate—PTGS2—Disease—DKK1—osteoporosis	6.04e-06	0.0019	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.88e-06	0.00185	CbGpPWpGaD
Salsalate—PTGS2—Disease—WNT1—osteoporosis	5.82e-06	0.00183	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—TPI1—osteoporosis	5.82e-06	0.00183	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.74e-06	0.00181	CbGpPWpGaD
Salsalate—PTGS2—Disease—FGA—osteoporosis	5.66e-06	0.00178	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—P4HB—osteoporosis	5.47e-06	0.00172	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GAPDH—osteoporosis	5.37e-06	0.00169	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ENO1—osteoporosis	5.32e-06	0.00168	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PSMA2—osteoporosis	5.25e-06	0.00165	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PSMA5—osteoporosis	5.25e-06	0.00165	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—RAP1A—osteoporosis	5.23e-06	0.00165	CbGpPWpGaD
Salsalate—PTGS2—Disease—ENO1—osteoporosis	5.05e-06	0.00159	CbGpPWpGaD
Salsalate—PTGS2—Disease—PSMA2—osteoporosis	4.97e-06	0.00157	CbGpPWpGaD
Salsalate—PTGS2—Disease—PSMA5—osteoporosis	4.97e-06	0.00157	CbGpPWpGaD
Salsalate—PTGS2—Disease—CALCA—osteoporosis	4.63e-06	0.00146	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.56e-06	0.00144	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CYP19A1—osteoporosis	4.26e-06	0.00134	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ENO1—osteoporosis	4.23e-06	0.00133	CbGpPWpGaD
Salsalate—PTGS2—Disease—KL—osteoporosis	4.21e-06	0.00133	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—PSMA2—osteoporosis	4.16e-06	0.00131	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—PSMA5—osteoporosis	4.16e-06	0.00131	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ADCY5—osteoporosis	3.48e-06	0.0011	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GPX1—osteoporosis	3.47e-06	0.00109	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CYP19A1—osteoporosis	3.38e-06	0.00106	CbGpPWpGaD
Salsalate—PTGS2—Disease—ADCY5—osteoporosis	3.3e-06	0.00104	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—MTHFR—osteoporosis	3.2e-06	0.00101	CbGpPWpGaD
Salsalate—PTGS2—Disease—MTHFR—osteoporosis	3.03e-06	0.000955	CbGpPWpGaD
Salsalate—PTGS2—Disease—IRS2—osteoporosis	2.88e-06	0.000908	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ADCY5—osteoporosis	2.76e-06	0.000869	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GPX1—osteoporosis	2.75e-06	0.000866	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—POMC—osteoporosis	2.56e-06	0.000805	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—MTHFR—osteoporosis	2.54e-06	0.0008	CbGpPWpGaD
Salsalate—PTGS2—Disease—IRS1—osteoporosis	2.52e-06	0.000793	CbGpPWpGaD
Salsalate—PTGS2—Disease—IL6R—osteoporosis	2.36e-06	0.000745	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—POMC—osteoporosis	2.03e-06	0.000639	CbGpPWpGaD
Salsalate—PTGS2—Disease—MYC—osteoporosis	1.4e-06	0.000441	CbGpPWpGaD
Salsalate—PTGS2—Disease—TGFB1—osteoporosis	1.4e-06	0.00044	CbGpPWpGaD
Salsalate—PTGS2—Disease—IL6—osteoporosis	1.05e-06	0.000332	CbGpPWpGaD
